Detalles de la búsqueda
1.
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Malar J;
21(1): 202, 2022 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35761273
2.
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.
Malar J;
21(1): 155, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35637506
3.
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso.
Antimicrob Agents Chemother;
65(8): e0087321, 2021 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34060901
4.
Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.
Malar J;
20(1): 64, 2021 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33514368
5.
Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso.
Trop Med Infect Dis;
8(4)2023 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104321
6.
Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso.
J Pediatric Infect Dis Soc;
12(9): 513-518, 2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589596
7.
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.
BMJ Open;
11(2): e040220, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589447
8.
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial.
Int J Infect Dis;
108: 465-472, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34082090
9.
Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15-23 months in Burkina Faso.
Int J Infect Dis;
102: 517-523, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33176205
10.
Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change.
Pan Afr Med J;
35: 68, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32537072
Resultados
1 -
10
de 10
1
Próxima >
>>